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Abstract Aging-induced pro-inflammatory phenotypic
alterations of the cerebral vasculature critically contribute
to the pathogenesis of vascular cognitive impairment. Cel-
lular senescence is a fundamental aging process that
promotes inflammation; however, its role in cerebrovascu-
lar aging remains unexplored. The present study was
undertaken to test the hypothesis that advanced aging
promotes cellular senescence in the cerebral vasculature.
We found that in cerebral arteries of 24-month-old mice,
expression of molecular markers of senescence (p16INK4a,
p21) is upregulated as compared to that in young controls.
Induction of senescence programs in cerebral arteries is
associated by an upregulation of a wide range of inflam-
matory cytokines and chemokines, which are known to
contribute to the senescence-associated secretory pheno-
type (SASP) in vascular cells. Age-related cerebrovascular
senescence and inflammation are associated with neuroin-
flammation, as shown by the molecular footprint of mi-
croglia activation in the hippocampus. Genetic depletion of
the pro-survival/anti-aging transcriptional regulator Nrf2
exacerbated age-related induction of senescence markers
and inflammatory SASP factors and resulted in a height-
ened inflammatory status of the hippocampus. In conclu-
sion, our studies provide evidence that aging and Nrf2
dysfunction promote cellular senescence in cerebral ves-
sels, whichmay potentially cause or exacerbate age-related
pathology.
Keywords Vascular aging . Senescence . Vascular
cognitive impairment . Endothelial dysfunction . VCID
Introduction
Aging-induced pro-inflammatory phenotypic alterations
of cerebral arteries and arterioles promote atherogenesis,
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dysregulation of cerebral blood flow, blood brain barrier
disruption and/or exacerbation of neuroinflammation,
significantly contributing to the pathogenesis of age-
related vascular cognitive impairment (VCI) (Toth
et al. 2017). Inflammation-related vascular contributions
to cognitive impairment are common in old age and play
critical roles in the pathogenesis of the entire spectrum
of cognitive impairment from mild to more severe
forms, including ischemic and hemorrhagic stroke, cog-
nitive impairment associated with subclinical microvas-
cular injury as well as Alzheimer’s disease. In order to
develop novel therapeutic interventions to promote ce-
rebrovascular health preserving cognitive function in
older persons, it is essential to understand the cellular
and molecular mechanisms through which aging pro-
motes vascular inflammation in the cerebral circulation.
Among the cellular and molecular mechanisms con-
tributing to organismal aging in recent years cellular
senescence has emerged as a fundamental aging process
(Baker et al. 2016; Jeon et al. 2017; Tchkonia et al.
2013). Upon induction of cellular senescence, cells per-
manently withdraw from the cell cycle and undergo
distinctive phenotypic alterations, including significant
pro-inflammatory secretome changes (Freund et al.
2010). Importantly, elimination of senescent cells ex-
pressing the cell cycle regulator protein p16INK4A
extends lifespan and health span in mice, reducing the
inflammatory status of many organs (Baker et al. 2016).
Activation of cellular senescence programs have also
been suggested to contribute to vascular pathology
(Regina et al. 2016; Wang et al. 2015; Yamazaki et al.
2016; Uryga and Bennett 2016; Gardner et al. 2015; Liu
et al. 2018; Silva et al. 2017; Matthews et al. 2006).
Despite these advances, the role of senescence in cere-
brovascular aging remains unexplored.
Nrf2 (NF-E2-related factor 2) is a key redox sensitive
transcription factor, which regulates the expression of
detoxification and antioxidant enzymes, factors in-
volved in repair of oxidative macromolecular damages
and other cell survival pathways and thereby exerts
multifaceted anti-aging vasoprotective effects (Tarantini
et al. 2018a; Ungvari et al. 2010; Ungvari et al. 2011a, b;
Valcarcel-Ares et al. 2012; Csiszar et al. 2012). In
healthy organisms, Nrf2-mediated homeostatic re-
sponses serve to attenuate vascular oxidative stress,
limit free radical-induced cellular and macromolecular
damages, and protect the viability and function of endo-
thelial cells (Ungvari et al. 2011a, b). Nrf2 was also
shown to inhibit pathways involved in induction of
cellular senescence (Zhou et al. 2016; Volonte et al.
2013; Kapeta et al. 2010). Several pathophysiological
conditions may impair the Nrf2 system, including met-
abolic diseases (Tan et al. 2011). There is increasing
evidence that Nrf2 dysfunction promote accelerated
vascular aging by impairing cellular stress resilience,
increasing oxidative stress and promoting inflammatory
phenotypic alterations (Tarantini et al. 2018a; Ungvari
et al. 2011c). Recent studies also demonstrate that while
Nrf2 dysfunction in cerebral microvessels in the absence
of an oxidative stressor in otherwise healthy young
animals do not impair endothelial barrier function
(Tarantini et al. 2018a; Joshi et al. 2015), it significantly
exacerbates metabolic stress-induced disruption of the
blood-brain barrier, contributing to increased microglia
activation, neuroinflammation and neuronal dysfunc-
tion (Tarantini et al. 2018a). Despite these advances,
the role of Nrf2 in protection against cellular
senescencein the cerebrovasculature has not yet been
explored.
The present study was undertaken to test the hypothesis
that advanced aging promotes cellular senescence in the
cerebral vasculature, which is exacerbated by Nrf2 defi-
ciency. To test our hypothesis, we assessed age-related
changes in expression of molecular markers of senescence
in mouse cerebral arteries. Induction of senescence pro-
grams in vascular endothelial and smooth muscle cells is
associated by an upregulation of a wide range of inflam-
matory cytokines and chemokines (Ungvari et al. 2013),
termed the Bsenescence-associated secretory phenotype,^
or SASP. Thus, as an additional outcomemeasure, we also
assessed vascular expression of pro-inflammatory SASP
factors. To determine the role of Nrf2 in regulation of
vascular senescence, cerebral arteries isolated from aged
Nrf2 deficient (Nrf2−/−) and wild-type mice were com-
pared. To determine the relationship among induction of
cerebrovascular senescence, vasomotor function and neu-
roinflammation, we assessed endothelium-mediated vaso-
dilation in cannulated, pressurized cerebral arteries and
characterized the molecular footprint of microglia activa-
tion in the mouse hippocampus.
Methods
Animal models
Male wild-type control C57BL/6J mice (Nrf2+/+; age 3
and 24 months old) and Nrf2 knockout mice (Nrf2−/−
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[B6.129X1-Nfe2l2tm1Ywk/J]; age 24 months old; pur-
chased from Jackson Laboratories; JAX stock
#017009) were used. In this study, only male mice were
studied to exclude the possible confounding effects of
the estrous cycle in females. The mice were housed in an
environmentally controlled vivarium with unlimited ac-
cess to water and a controlled photoperiod (12-h light;
12-h dark). All mice were maintained according to
National Institutes of Health guidelines and all animal
use protocols were approved by the Institutional Animal
Care and Use Committee of the University of Oklahoma
HSC.
Assessment of endothelial NO-mediated vasodilation
in isolated cerebral vessels
As impaired cerebrovascular dilation plays an important
role in the pathogenesis of cognitive impairment (Csiszar
et al. 2017; Tarantini et al. 2017a, b; Tucsek et al. 2017;
Ungvari et al. 2017a), we assessed the effects of aging and
Nrf2 deficiency on endothelial NO mediation in isolated,
cannulated, and pressurized segments of the middle cere-
bral arteries, as reported (Tarantini et al. 2018b). Dilations
to acetylcholine andATPwere obtained in the absence and
presence of L-NAME (3 × 10−4 mol/L, for 30 min). At the
end of each experiment, the vessels were superfused with
Ca2+-free Krebs’ buffer containing nifedipine (10−5 mol/L)
to achieve maximal vasodilatation.
Assessment of the integrity of the blood-brain barrier
To quantify blood-brain barrier (BBB) permeability, we
used the sodium fluorescein tracer assay as reported (Toth
et al. 2013). In brief, in anesthetized mice, the small water-
soluble tracer sodium fluorescein (5 ml/kg, 2% in physio-
logical saline) was administered intravenously by
retroorbital injection. After 30 min of circulation of the
tracer, animals were transcardially perfused with 1× hepa-
rin containing PBS. Then, the mice were decapitated and
the brains were removed. From each brain, the hippocam-
pus, white matter, and the prefrontal cortex were isolated
and homogenized. The extravasated sodium fluorescein
was quantified spectrophotofluorometrically using a mi-
croplate reader and normalized to tissue weight.
Quantitative real-time RT-PCR
A quantitative real-time RT-PCR technique was used to
analyze mRNA expression in middle cerebral arteries
and hippocampal samples (collected using standard iso-
lation protocols (Tarantini et al. 2018b)), using validated
TaqMan probes (Applied Biosystems) and a Strategen
MX3000 platform (Tarantini et al. 2018b).
Statistical analysis
Data were analyzed by one-way analysis of variance
(ANOVA) followed by Tukey’s post hoc test. A p value
less than 0.05 was considered statistically significant.
Data are expressed as mean ± S.E.M.
Results
Nrf2 deficiency exacerbates aging-induced cellular
senescence in cerebral arteries
The senescence response induced by oxidative stress and
DNA damage in cerebromicrovascular endothelial cells is
controlled by a signaling pathway that leads to induction of
cyclin-dependent kinase inhibitors p16INK4a (CDKN2A)
and p21 (CDKN1A) (Ungvari et al. 2013). Here, we report
that aging is associated with upregulation of these molec-
ular markers of senescence in cerebral arteries, which is
exacerbated by genetic depletion of Nrf2 (Fig. 1a).
Effects of Nrf2 deficiency and aging on endothelial
function in cerebral arteries
To determine how Nrf2 depletion affects endothelial func-
tion, endothelium-dependent vasodilator responses were
tested in isolated, cannulated branches of the middle cere-
bral artery. In young vessels, administration of ATP result-
ed in significant dilation, whereas these responses were
significantly attenuated in vessels derived from aging mice
(Fig. 1b). Genetic depletion of Nrf2 tended to further
impair ATP-induced vasodilation; yet, these differences
did not reach statistical significance. To assess the role of
endothelium-derived NO, the eNOS inhibitor L-NAME
was applied. L-NAME abolished ATP-induced dilator
responses, eliminating the differences between the three
groups (data not shown).
Nrf2 deficiency exacerbates aging-induced
inflammation in cerebral arteries
Previous studies show that senescent vascular endothe-
lial cells and smooth muscle cells acquire a complex
GeroScience (2018) 40:513–521 515
phenotype that includes the secretion of many inflam-
matory cytokines and chemokines, termed a
senescence-associated secretory phenotype (SASP)
(Ungvari et al. 2013). It has been proposed that SASP
in endothelial and smooth muscle cells contribute to
age-related vascular inflammation (Ungvari et al.
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2018). Here, we report that increased cellular senes-
cence is associated with pro-inflammatory phenotypic
changes in aged cerebral arteries, which include upreg-
ulation of the SASP factors IL-1β and TNFα (Fig. 1c).
Genetic depletion of Nrf2 exacerbated the age-related
upregulation of multiple SASP factors, including cyto-
kines, chemokines, IGF-1 binding proteins, and matrix
metalloproteinases (MMPs; Fig. 1c).
Effects of aging and Nrf2 deficiency on BBB integrity
and the hippocampal expression of genes involved
in microglia activation and neuroinflammation
Using a sodium fluorescein tracer assay, we found that
Nrf2 depletion exacerbates aging-induced fluorescein
leakage in the hippocampi indicating BBB disruption
(fold changes; aged Nrf2+/+: ~1.2; aged Nrf2−/−: ~1.9 vs.
young controls). Gene expression profiling demonstrat-
ed that age-related BBB disruption and cerebrovascular
inflammation is associated with a cerebral gene expres-
sion signature indicative of microglia activation (Fig.
1d), extending previous findings both in human
(Berchtold et al. 2008) and mouse (Masser et al. 2014;
Mangold et al. 2017) hippocampi. Previous studies sug-
gest that pro-inflammatory vascular phenotype exacer-
bates neuroinflammation, in part by promoting leakage
of plasma-derived factors through the damaged BBB
(Toth et al. 2013), which is a potent stimulus for mi-
croglia activation (Tucsek et al. 2014). In accordance
with this concept, we found that in the hippocampi of
aged mice Nrf2 depletion promoted significant upregu-
lation of microglia-enriched pro-inflammatory genes
(Fig. 1d).
Discussion
Results from the present study demonstrate for the
first time that advanced aging promotes cellular
senescence in the cerebral arteries, as indicated by
the increased expression of several independent mo-
lecular markers of senescence (Fig. 1a). Further
s tud i e s a re needed to de t e rmine whe the r
p16INK4A-mediated senescence programs are pri-
marily induced in aged endothelial cells, smooth
muscle cells or in adventitial cells.
The stress-activated Bcap'n'collar^ transcription factor
Nrf2 plays an important role in regulating the aging
process by orchestrating the transcriptional response of
cells to oxidative stress and DNA damage (Pearson et al.
2008a). Regulation of the expression of antioxidant en-
zymes and DNA repair pathways by homologs of Nrf2 is
evolutionarily highly conserved and studies on model
organisms demonstrate that knockdown of homologs of
Nrf2 shortens lifespan (Jasper 2008). Previous studies
also demonstrate that Nrf2 contributes to the anti-aging
effects of caloric restriction in rodent models (Pearson
et al. 2008a). Our findings that aging-induced
p16INK4A-mediated cellular senescence in cerebral ves-
sels is exacerbated by genetic disruption of the Nrf2-
dependent cytoprotective pathways suggest that age-
related increased oxidative stress and consequential
DNA damage are likely critical inducers of the senescent
program in vascular cells. These results extend those of
previous studies demonstrating a critical role for in-
creased oxidative stress in functional and phenotypic
alterations in the aged cerebral vasculature (Tarantini
et al. 2018b). We posit that attenuation of oxidative stress
and inhibition of cellular senescence may critically con-
tribute both to the established anti-aging (Pearson et al.
2008a) and vasoprotective effects (Ungvari et al. 2010;
Valcarcel-Ares et al. 2012; Ungvari et al. 2011c) of Nrf2.
This concept is supported by the findings that Nrf2 defi-
ciency exacerbates oxidative stress and promotes accel-
erated cerebrovascular aging in mice exposed to high fat
diet-induced metabolic stress, which is associated with
increased senescence (Tarantini et al. 2018a).
Fig. 1 Nrf2 deficiency exacerbates cerebrovascular senescence,
promoting inflammation in aging. a Nrf2 deficiency exacerbates
age-related upregulation of mRNA expression (qPCR) of the
senescence markers Cdkn2a and Cdkn1a (encoding p16INK4 and
p21, respectively) in mouse cerebral arteries. b Effects of aging
andNrf2 deficiency onATP-induced dilation of cannulated middle
cerebral arteries. c Nrf2 deficiency exacerbates age-related
upregulation of mRNA expression of pro-inflammatory SASP
factors in in mouse cerebral arteries. d Gene expression footprint
of microglia activation. The heat map shows relative changes in
mRNA expression (qPCR) ofmicroglia activation-related genes in
the hippocampi of aged Nrf2+/+ and Nrf2−/− mice as compared to
that in young mice. Data are means ± S.E.M. (n = 6–8 in each
group), *P < 0.05 vs. young, #P < 0.05 vs. aged Nrf2+/+. e
Proposed scheme showing that Nrf2 dysfunction exacerbates
aging-induced cerebrovascular senescence, which likely
contributes to the pathogenesis of cognitive impairment by
promoting neuroinflammation (due to the paracrine effects of the
pro-inflammatory SASP and/or by disrupting the blood-brain
barrier (Tarantini et al. 2018a)) and microvascular rarefaction
(Valcarcel-Ares et al. 2012; Ungvari et al. 2013)
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From a pathophysiological standpoint, activation of
senescence programs in the aged cerebral vasculature is
expected to impair vasomotor function and angiogenesis
and promote inflammation contributing to the develop-
ment of cerebrovascular diseases and vascular cognitive
impairment. This conclusion is supported by the results of
previous studies showing that DNA damage-induced se-
nescence is associated with impaired neurovascular cou-
pling, capillary rarefaction and upregulation of inflamma-
tory processes in a mouse models of whole brain
irradiation-induced accelerated brain aging (Ungvari et al.
2013, 2017b). Advanced atherosclerotic lesions also con-
tain senescent cells and previous investigations using ge-
netic and pharmacological approaches to eliminate senes-
cent cells in Ldlr−/−mice suggest that senescent cells pro-
mote the development of atherosclerotic vascular diseases
(Childs et al. 2016). Importantly, chronic treatment with
senolytic drugs was also demonstrated to improve endo-
thelial function in mouse models of aging (Roos et al.
2016). Importantly, Nrf2 deficiency, which promotes se-
nescence , inh ib i t s ang iogen ic capac i ty of
cerebromicrovascular endothelial cells (Valcarcel-Ares
et al. 2012), exerts pro-atherogenic effects, and exacerbates
endothelial dysfunction (Tarantini et al. 2018a).
p16INK4A-mediated cellular senescence in vascular cells
is known to be associatedwith the development of a highly
pro-inflammatory SASP (Ungvari et al. 2013). Induction
of senescence programs in aged cerebral arteries is also
associated by an upregulation of a wide range of inflam-
matory mediators (cytokines, chemokines and MMPs),
consistent with the induction of a SASP. Additionally,
inflammatory foci associated with senescence vascular
endothelial and/or smooth muscle cells likely disrupt the
blood brain barrier (e.g., due to the upregulation of matrix
metalloproteinases, which degrade the extracellular ma-
trix). Inflammatory factors released from the vasculature
and plasma-derived factors leaking through the damaged
blood-brain barrier are expected to promote microglia
activation and thereby exacerbate neuroinflammation.
Analysis of the gene expression footprint of microglia
activation in agedNrf2 deficientmice provides preliminary
evidence that induction of cerebrovascular senescence as-
sociates with increased neuroinflammation.
A number of important limitations of the present
study need to be considered. First, direct demonstration
of senescent cells in the cerebral vessels (e.g., using
senescence reporter mice) should be performed in future
studies. Second, further studies are warranted to eluci-
date the exact molecular mechanisms by which
senescence endothelial cells contribute to BBB disrup-
tion, including dysregulation of tight junction
(Yamazaki et al. 2016) and the paracrine role of SASP.
Future studies are warranted to experimentally test role
of cerebrovascular senescence in induction of neuroin-
flammation and their contribution to cognitive decline.
Subsequent studies should also test the synergistic ef-
fects of aging and Nrf2 depletion on other aspects of
endothelial phenotype as well, including neurovascular
coupling responses, microvascular network architecture
and capillary density.
In conclusion, our studies provide evidence that aging
promotes cellular senescence in cerebral vessels, which is
exacerbated by impaired cellular resilience linked to the
depletion of the highly conserved anti-aging transcription
factor Nrf2. Previous studies suggest that Nrf2 may pro-
vide a therapeutic target for cerebrovascular protection
countering oxidative stress associated with aging and path-
ological conditions characterized by accelerated vascular
aging (Tarantini et al. 2018a; Ungvari et al. 2011b, c). In
that regard, it is significant that in vascular cells Nrf2 can
be activated pharmacologically (Ungvari et al. 2010),
which was shown to confer vasoprotection in rodent
models of aging, upregulating antioxidant systems, de-
creasing oxidative stress and attenuating vascular inflam-
mation (Pearson et al. 2008b). Further studies are warrant-
ed to determine whether chronic treatment with Nrf2 acti-
vators can protect against induction of cellular senescence
in the cerebral circulation, mitigating its deleterious conse-
quences in the aging brain. In recent years, microvascular
contributions to neurodegeneration as well as the role of
cellular senescence and the senescent secretory phenotype
to brain pathologies have been increasingly recognized.
Importantly, previous studies demonstrated that intact Nrf2
signaling protects against oxidative stress-mediated cellu-
lar damage and neurotoxicity in mouse models of
Parkinson’s disease (Rojo et al. 2010) and Alzheimer’s
disease (Joshi et al. 2015). Thus, further studies are war-
ranted to determine the link between Nrf2 signaling in the
vascular cells and senescence-induced sterile microvascu-
lar inflammation in neurodegenerative diseases and devel-
op therapies targeting Nrf2 for microvascular protection
and prevention of dementia.
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